SCHEMBL1269828

SCHEMBL1269828

Cc1nc(NS(=O)(=O)c2ccc(Cl)cc2)ncc1Sc1ccc(S(=O)(=O)N2CCCCC2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 12/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ L3MBTL1 Q9Y468 5/20 0.45
▸ MEN1 O00255 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ LMNA P02545 4/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ MAPT P10636 3/20 0.44
▸ USP2 O75604 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ OPRK1 P41145 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ POLB P06746 2/20 0.42
▸ APEX1 P27695 1/20 0.42
▸ RECQL P46063 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1269394 0.90 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL1269635 0.86 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL1268549 0.86 L3MBTL1 (0.42) ALDH1A1SMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL1269447 0.85 L3MBTL1 (0.41) ALDH1A1SMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL1268542 0.83 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL1268839 0.81 MEN1 (0.42) ALDH1A1SMN1; SMN2MEN1KMT2ALMNA
SCHEMBL1269541 0.80 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL1269543 0.79 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL12931650 0.79 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2L3MBTL1MEN1KMT2A
SCHEMBL1268550 0.78 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-20060084802-A1 Bisaryl-sulfonamides AMGEN INC. 2006-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221584-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG ALDH1A1 2237/4885SMN1; SMN2 4836/4885L3MBTL1 3486/4885
US-20060084802-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG ALDH1A1 2237/4885SMN1; SMN2 4836/4885L3MBTL1 3486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback